Analyst firms · Raymond James · TNDM

Raymond James TNDM price target and rating history

Tandem Diabetes Care Inc. (TNDM) · Health Care

Raymond James rates Tandem Diabetes Care Inc. (TNDM) Mkt Perform with a $138 price target, as of its latest action on Apr 24, 2023. It has published 3 rating actions on TNDM since August 2021, including 0 upgrades and 1 downgrade. Across 12 firms with a TNDM price target in the last 12 months, the median target is $26.50.

Current rating
Mkt Perform
Price target
$138
Median target, all firms
$26.50
Actions on TNDM
3

Raymond James price target on TNDM

$138$129$12020222023202420252026
Raymond James price target on TNDM, each point a stated target, August 2021 to November 2021.

Every Raymond James rating on TNDM

How other firms rate TNDM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StifelBuy$26Nov 18, 2026
BarclaysEqual Weight$18Oct 7, 2026
CitigroupNeutral$20Sep 30, 2026
William BlairOutperformAug 21, 2026
UBSNeutral$18Jul 28, 2026
Deutsche BankHold$15.50Jun 23, 2026
Wells FargoOverweight$27Jun 1, 2026
The Benchmark CompanyHoldMay 12, 2026
Truist SecuritiesBuy$35Mar 19, 2026
Piper SandlerOverweight$33Mar 17, 2026
Lake StreetBuy$50Feb 23, 2026
BofA SecuritiesNeutral$30Feb 20, 2026
TD CowenBuy$25Jan 27, 2026
Robert W. BairdOutperform$30Dec 16, 2025

Questions about Raymond James and TNDM

What is Raymond James's price target for TNDM?
Raymond James's latest stated price target for Tandem Diabetes Care Inc. (TNDM) is $138, from its action on Nov 4, 2021.
What is Raymond James's rating on TNDM?
Raymond James rates TNDM Mkt Perform, a neutral rating, as of Apr 24, 2023.
When did Raymond James last change its view on TNDM?
On Apr 24, 2023, Raymond James downgrades to Mkt Perform from Outperform.
How does Raymond James's TNDM target compare with other analysts?
Across 12 firms with a TNDM price target in the last 12 months, the median target is $26.50.

More TNDM rating histories

All Raymond James ratingsTNDM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.